Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Jasper Therapeutics Inc (JSPR)

56 + Investors. Track Smart Money conviction in JSPR. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +2
Streak
1Q ▲
Buyers last Q
53%

Smart Money Signals — JSPR

Based on 56 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added JSPR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🔻

Below peak — only 66% of 3.0Y high

66% of all-time peak
Only 56 funds hold JSPR today versus a peak of 85 funds at 2024 Q4 — just 66% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 16% fewer funds vs a year ago

fund count last 6Q
11 fewer hedge funds hold JSPR compared to a year ago (-16% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟡

Slight buying edge — 53% buying

28 buying25 selling
Last quarter: 28 funds bought or added vs 25 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~12 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 16 → 16 → 10 → 12. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 30% long-term, 39% new

■ 30% conviction (2yr+) ■ 30% medium ■ 39% new
Of the 56 current holders: 17 (30%) held >2 years, 17 held 1–2 years, and 22 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares -15%, value -59%

Value
-59%
Shares
-15%
Last quarter: funds added -15% more shares while total portfolio value only changed -59%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

12 → 16 → 16 → 10 → 12 new funds/Q
New funds entering each quarter: 16 → 16 → 10 → 12. JSPR is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
📊

Mixed cohorts — 3% veterans, 41% new entrants

■ 3% veterans ■ 55% 1-2yr ■ 41% new
Of 58 current holders: 2 (3%) held 2+ years, 32 held 1–2 years, 24 (41%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
16 of 55 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
2.3
out of 10
Low Exit Risk
Exit risk score 2.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — JSPR

In 2026 Q1, 28 hedge funds were net buyers of JSPR (12 opened a new position, 16 added to an existing one), while 25 reduced or exited (15 trimmed, 10 sold completely) — a 53% buyer ratio, indicating a slight buying edge. 24% of total institutional value in JSPR is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +2 funds (more new holders than closures). Total institutional holders: 56.

Hedge Fund Ownership: JSPR

How many hedge funds hold JSPR — quarterly history vs. share price
Quarterly hedge fund ownership of JSPR vs. share price

Market Analysis: JSPR

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: JSPR

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Jasper Therapeutics Inc (JSPR) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much JSPR has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 89d ago
JSPR
-61.1%
XLV
+9.2%

JSPR outperformed XLV by -70.3% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 44d ago
JSPR
-59.9%
XLV
+10.3%

Since the filing became public, JSPR outperformed XLV by -70.2% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 1 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
1.3
/ 10
conviction
Hedge Fund Positioning: JSPR
56 + Investors

Track Smart Money conviction in JSPR. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 56 54 3.7%
13F Shares 16M 19M -15.26%
Total Value $14M $34M -59.45%
New Positions 12 10 +2
Increased Positions 15 22 -7
Closed Positions 10 16 -6
Reduced Positions 13 12 +1
Total Calls 2 3 -33.33%
Total Puts 1 2 -50.0%
PUT/CALL Ratio 0.5 0.67 Bullish

Statistics: JSPR

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

56 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in JSPR. Verified SEC 13F-HR filings.

QUARTER:
Top 25 JSPR holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Lion Point Capital, LP 2.44% 465,000 $407K
2 Velan Capital Investment Management LP 1.46% 2,668,395 $2.3M
3 Acorn Capital Advisors, LLC 0.35% 1,411,492 $1.2M
4 Kingdon Capital Management, L.L.C. 0.13% 1,352,106 $1.2M
5 Knott David M Jr 0.08% 160,789 $141K
6 Verdad Advisers, LP 0.07% 73,967 $65K
7 Rock Springs Capital Management LP 0.06% 1,100,726 $964K
8 Diker Management LLC 0.03% 35,000 $31K
9 Quarry LP 0.02% 131,529 $115K
10 Soleus Capital Management, L.P. 0.01% 276,312 $242K
11 Carlyle Group Inc. 0.01% 1,066,189 $934K
12 ADAR1 Capital Management, LLC 0.01% 140,000 $123K
13 Boothbay Fund Management, LLC 0.01% 582,751 $511K
14 NINE MASTS CAPITAL Ltd 0.01% 44,165 $39K
15 Sequent Planning LLC 0.00% 14,900 $13K
16 Ikarian Capital, LLC 0.00% 24,093 $21K
17 Jacobs Levy Equity Management, Inc 0.00% 322,273 $282K
18 Readystate Asset Management LP 0.00% 27,499 $24K
19 Rehmann Capital Advisory Group 0.00% 15,300 $13K
20 XTX Topco Ltd 0.00% 39,431 $35K
21 Millennium Management LLC 0.00% 1,617,531 $1.4M
22 Engineers Gate Manager LP 0.00% 26,131 $23K
23 Renaissance Technologies LLC 0.00% 177,500 $156K
24 Ieq Capital, LLC 0.00% 51,428 $45K
25 Tower Research Capital LLC (TRC) 0.00% 6,305 $6K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Jasper Therapeutics Inc (JSPR)

What does the Smart Money Trend signal show for JSPR?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added JSPR than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for JSPR?

Slight buying edge — 53% buying: Last quarter: 28 funds bought or added vs 25 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for JSPR holders?

Strong quality — 24% AUM from major funds: 16 of 55 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held JSPR?

Mixed — 30% long-term, 39% new: Of the 56 current holders: 17 (30%) held >2 years, 17 held 1–2 years, and 22 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Jasper Therapeutics Inc (JSPR) following the 2026 Q1 hedge fund 13F filings?

As of today, JSPR has moved -59.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +10.3% for the XLV sector ETF — an outperformance of -70.2%. Since the quarter end (March 31, 2026), JSPR has gained -61.1% vs +9.2% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →